HME Debate 2020

HME Debate 2020

6 & 7 February 2020
Geneva
Please note that you must sign up for each broadcast to be able to view the on – demand version.
You can sign up here:
An update on advanced therapy medicinal products: What’s new from ASH 2019
7 February 2020 - 38 Minutes

An update on advanced therapy medicinal products: What’s new from ASH 2019

On February 6th and 7th we will broadcast the plenary sessions live from the Debate. Our expert faculties will discuss the importance of recent data including data presented during the American Society of Hematology (ASH) 2019 congress relating to the management of patients with acute myeloid leukemia, chronic lymphocytic leukemia, B-cell lymphomas and multiple myeloma. A focus will be on ...

more info...

EM-25773
An update from ASH 2019 on the management of patients with relapsed / refractory MM
7 February 2020 - 47 Minutes

An update from ASH 2019 on the management of patients with relapsed / refractory MM

On February 6th and 7th we will broadcast the plenary sessions live from the Debate. Our expert faculties will discuss the importance of recent data including data presented during the American Society of Hematology (ASH) 2019 congress relating to the management of patients with acute myeloid leukemia, chronic lymphocytic leukemia, B-cell lymphomas and multiple myeloma. A focus will be on ...

more info...

EM-25772
Current considerations in management of patients with newly-diagnosed MM
7 February 2020 - 63 Minutes

Current considerations in management of patients with newly-diagnosed MM

On February 6th and 7th we will broadcast the plenary sessions live from the Debate. Our expert faculties will discuss the importance of recent data including data presented during the American Society of Hematology (ASH) 2019 congress relating to the management of patients with acute myeloid leukemia, chronic lymphocytic leukemia, B-cell lymphomas and multiple myeloma. A focus will be on ...

more info...

EM-25769
Updates from ASH 2019 relating to the management of patients with acute myeloid leukemia (AML) and selected B-cell lymphomas
6 February 2020 - 64 Minutes

Updates from ASH 2019 relating to the management of patients with acute myeloid leukemia (AML) and selected B-cell lymphomas

On February 6th and 7th we will broadcast the plenary sessions live from the Debate. Our expert faculties will discuss the importance of recent data including data presented during the American Society of Hematology (ASH) 2019 congress relating to the management of patients with acute myeloid leukemia, chronic lymphocytic leukemia, B-cell lymphomas and multiple myeloma. A focus will be on ...

more info...

EM-25768
Choosing the right strategy for the management of patients with relapsed CLL
6 February 2020 - 42 Minutes

Choosing the right strategy for the management of patients with relapsed CLL

On February 6th and 7th we will broadcast the plenary sessions live from the Debate. Our expert faculties will discuss the importance of recent data including data presented during the American Society of Hematology (ASH) 2019 congress relating to the management of patients with acute myeloid leukemia, chronic lymphocytic leukemia, B-cell lymphomas and multiple myeloma. A focus will be on ...

more info...

EM-25767
Selecting first-line treatment for patients with chronic lymphocytic leukemia (CLL) in 2020
6 February 2020 - 73 Minutes

Selecting first-line treatment for patients with chronic lymphocytic leukemia (CLL) in 2020

On February 6th and 7th we will broadcast the plenary sessions live from the Debate. Our expert faculties will discuss the importance of recent data including data presented during the American Society of Hematology (ASH) 2019 congress relating to the management of patients with acute myeloid leukemia, chronic lymphocytic leukemia, B-cell lymphomas and multiple myeloma. ...

more info...

EM-25764